Trade Summary

3 days ago, ROBIN HOWARD W, serving as President & CEO at NEKTAR THERAPEUTICS (NKTR), sold 20,000 shares at $60.75 per share, for a total transaction value of $1,215,055.78. Following this transaction, ROBIN HOWARD W now holds 55,045 shares of NKTR.

This sale represents a 26.65% decrease in ROBIN HOWARD W's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 16, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 18, 2026 at 7:08 PM ET, 2 days after the trade was made.

NEKTAR THERAPEUTICS operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.